| microRNA-145 mediates the inhibitory effect of adipose tissue-derived stromal cells on prostate cancer K Takahara, M Ii, T Inamoto, T Nakagawa, N Ibuki, Y Yoshikawa, T Tsujino, ... Stem cells and development 25 (17), 1290-1298, 2016 | 98 | 2016 |
| SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells Y Kuranaga, N Sugito, H Shinohara, T Tsujino, K Taniguchi, K Komura, ... International journal of molecular sciences 19 (10), 3012, 2018 | 93 | 2018 |
| A novel combination RNAi toward Warburg effect by replacement with miR-145 and silencing of PTBP1 induces apoptotic cell death in bladder cancer cells T Takai, Y Yoshikawa, T Inamoto, K Minami, K Taniguchi, N Sugito, ... International journal of molecular sciences 18 (1), 179, 2017 | 41 | 2017 |
| Impairment of K‐Ras signaling networks and increased efficacy of epidermal growth factor receptor inhibitors by a novel synthetic miR‐143 Y Akao, M Kumazaki, H Shinohara, N Sugito, Y Kuranaga, T Tsujino, ... Cancer science 109 (5), 1455-1467, 2018 | 39 | 2018 |
| C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma–A data from multi-institutional study in Japan T Tsujino, K Komura, T Hashimoto, R Muraoka, N Satake, T Matsunaga, ... Urologic Oncology: Seminars and Original Investigations 37 (11), 812. e1-812. e8, 2019 | 38 | 2019 |
| Synthetic miR-143 exhibited an anti-cancer effect via the downregulation of K-RAS networks of renal cell cancer cells in vitro and in vivo T Takai, T Tsujino, Y Yoshikawa, T Inamoto, N Sugito, Y Kuranaga, ... Molecular Therapy 27 (5), 1017-1027, 2019 | 33 | 2019 |
| MicroRNA‐143/Musashi‐2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer T Tsujino, N Sugito, K Taniguchi, R Honda, K Komura, Y Yoshikawa, ... Cancer science 110 (7), 2189-2199, 2019 | 32 | 2019 |
| Preoperative measurement of the modified glasgow prognostic score predicts patient survival in non-metastatic renal cell carcinoma prior to nephrectomy T Tsujino, K Komura, T Matsunaga, Y Yoshikawa, T Takai, T Uchimoto, ... Annals of surgical oncology 24, 2787-2793, 2017 | 30 | 2017 |
| The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma T Tsujino, K Komura, A Ichihashi, T Tsutsumi, T Matsunaga, Y Yoshikawa, ... Oncotarget 8 (66), 110311, 2017 | 29 | 2017 |
| CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer T Tsujino, T Takai, K Hinohara, F Gui, T Tsutsumi, X Bai, C Miao, C Feng, ... Nature Communications 14 (1), 252, 2023 | 26 | 2023 |
| The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma T Inamoto, H Matsuyama, S Sakano, N Ibuki, K Takahara, K Komura, ... Oncotarget 8 (68), 113248, 2017 | 23 | 2017 |
| Synthetic miR-143 inhibits growth of HER2-positive gastric cancer cells by suppressing KRAS networks including DDX6 RNA helicase Y Tokumaru, T Tajirika, N Sugito, Y Kuranaga, H Shinohara, T Tsujino, ... International Journal of Molecular Sciences 20 (7), 1697, 2019 | 20 | 2019 |
| CRISPR screen contributes to novel target discovery in prostate cancer T Tsujino, K Komura, T Inamoto, H Azuma International Journal of Molecular Sciences 22 (23), 12777, 2021 | 19 | 2021 |
| Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents K Komura, T Inamoto, T Tsujino, Y Matsui, T Konuma, K Nishimura, ... Oncogene 40 (43), 6210-6222, 2021 | 19 | 2021 |
| RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer C Miao, T Tsujino, T Takai, F Gui, T Tsutsumi, Z Sztupinszki, Z Wang, ... Science Advances 8 (7), eabl9794, 2022 | 18 | 2022 |
| Prognostic impact of C-reactive protein-albumin ratio for the lethality in castration-resistant prostate cancer T Uchimoto, K Komura, Y Fujiwara, K Saito, N Tanda, T Matsunaga, ... Medical Oncology 37, 1-9, 2020 | 18 | 2020 |
| Anti-cancer effects of a chemically modified miR-143 on bladder cancer by either systemic or intravesical treatment Y Yoshikawa, K Taniguchi, T Tsujino, K Heishima, T Inamoto, T Takai, ... Molecular Therapy-Methods & Clinical Development 13, 290-302, 2019 | 17 | 2019 |
| The CANLPH score, an integrative model of systemic inflammation and nutrition status (SINS), predicts clinical outcomes after surgery in renal cell carcinoma: data from a … K Komura, T Hashimoto, T Tsujino, R Muraoka, T Tsutsumi, N Satake, ... Annals of surgical oncology 26, 2994-3004, 2019 | 16 | 2019 |
| Risk classification for overall survival by the neutrophil–lymphocyte ratio and the number of metastatic sites in patients treated with pembrolizumab—a multicenter … T Uchimoto, K Komura, W Fukuokaya, T Kimura, K Takahashi, Y Yano, ... Cancers 13 (14), 3554, 2021 | 13 | 2021 |
| Comparison of radiographic progression-free survival and PSA response on sequential treatment using abiraterone and enzalutamide for newly diagnosed castration-resistant … K Komura, Y Fujiwara, T Uchimoto, K Saito, N Tanda, T Matsunaga, ... Journal of clinical medicine 8 (8), 1251, 2019 | 12 | 2019 |
